ResMed Inc (RMD)
221.70
+5.84
(+2.71%)
USD |
NYSE |
May 15, 14:52
ResMed Accounts Receivable (Quarterly): 779.26M for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 779.26M |
December 31, 2023 | 729.74M |
September 30, 2023 | 692.39M |
June 30, 2023 | 704.91M |
March 31, 2023 | 686.26M |
December 31, 2022 | 672.27M |
September 30, 2022 | 620.48M |
June 30, 2022 | 575.95M |
March 31, 2022 | 508.58M |
December 31, 2021 | 526.04M |
September 30, 2021 | 575.55M |
June 30, 2021 | 614.29M |
March 31, 2021 | 525.01M |
December 31, 2020 | 509.36M |
September 30, 2020 | 464.89M |
June 30, 2020 | 474.64M |
March 31, 2020 | 554.86M |
December 31, 2019 | 528.04M |
September 30, 2019 | 493.84M |
June 30, 2019 | 528.48M |
March 31, 2019 | 511.40M |
December 31, 2018 | 477.19M |
September 30, 2018 | 463.74M |
June 30, 2018 | 483.68M |
March 31, 2018 | 498.42M |
Date | Value |
---|---|
December 31, 2017 | 482.93M |
September 30, 2017 | 431.35M |
June 30, 2017 | 450.53M |
March 31, 2017 | 413.61M |
December 31, 2016 | 383.99M |
September 30, 2016 | 347.14M |
June 30, 2016 | 382.09M |
March 31, 2016 | 358.17M |
December 31, 2015 | 331.75M |
September 30, 2015 | 327.17M |
June 30, 2015 | 362.57M |
March 31, 2015 | 345.48M |
December 31, 2014 | 340.43M |
September 30, 2014 | 328.59M |
June 30, 2014 | 359.59M |
March 31, 2014 | 337.57M |
December 31, 2013 | 301.63M |
September 30, 2013 | 282.42M |
June 30, 2013 | 318.35M |
March 31, 2013 | 293.49M |
December 31, 2012 | 281.44M |
September 30, 2012 | 266.54M |
June 30, 2012 | 283.16M |
March 31, 2012 | 267.93M |
December 31, 2011 | 238.76M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
464.89M
Minimum
Sep 2020
779.26M
Maximum
Mar 2024
588.24M
Average
565.21M
Median
Accounts Receivable (Quarterly) Benchmarks
Boston Scientific Corp | 2.304B |
Align Technology Inc | 950.74M |
Stryker Corp | 3.473B |
Integer Holdings Corp | 237.15M |
Insulet Corp | 320.50M |